ChAdOx1 RVF
- Generic Name
- ChAdOx1 RVF
Safety and Immunogenicity of a Candidate Rift Valley Fever Vaccine (RVF003)
Phase 2
Not yet recruiting
- Conditions
- Rift Valley Fever
- Interventions
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 240
- Registration Number
- NCT06799234
- Locations
- 🇰🇪
KEMRI-Wellcome Trust Research Programme, Kilifi, Coast, Kenya
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath